Study details
Enrolling now
Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity
Deliberate Solutions Inc.
NCT IDNCT06923995ClinicalTrials.gov data as of Apr 2026
Target enrollment
120
Study length
about 6 months
Ages
18–65
Locations
1 site in TX
What this study is about
This trial is testing a new way to measure depression and anxiety using artificial intelligence. The goal is to see if this AI tool can provide reliable assessments of mood and anxiety disorders, potentially improving the development of new treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.AI-driven clinical interview
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: HAM-D ICC
Secondary: HAM-A ICC, MADRS ICC
Body systems
Psychiatry / Mental Health